When John Charman parted company with Ace in March 2001 he spent just eight months on the sidelines before officially re-entering the market as president and CEO of post-9/11 start-up Axis Specialty after a $1.6bn fund-raise.
But after eleven-and-a-half years at the (re)insurer, now known as Axis Capital, a swift return to the market following his ousting yesterday as chairman is likely to prove challenging.
Charman's employment agreement with the Bermudian includes non-compete and non-solicitation provisions for a period of...
You are currently viewing an incomplete version of this article. If you are a subscriber then please login now. If you are a non-subscriber but would like to be able to view this article, then please select from the purchasing options below.